Global Macro - The July CPI in the US increased by 2.7% year-on-year, matching the previous month and below the expected 2.8% [2] - The core CPI rose to 3.1% year-on-year, up from 2.9% in the previous month, indicating a continuous increase over three months [2] - Energy prices have significantly contributed to the decline in inflation, with international oil prices dropping due to easing geopolitical tensions [4] - The core goods and services prices have both risen, with tariffs not fully reflected in the current inflation data as US companies absorbed over 50% of the tariff costs [2][4] Interest Rate Outlook - The probability of a rate cut in September has increased to 93.6%, with expectations of nearly three cuts throughout the year [2] - The soft non-farm payroll data in July raises concerns about employment, making a rate cut a reasonable action for the Federal Reserve [3] - The upcoming Jackson Hole conference may provide signals regarding potential rate cuts from the Federal Reserve [3] Core Inflation Dynamics - Core goods prices have risen for four consecutive months, driven by tariff impacts on furniture and used car prices [4] - Supercore inflation, excluding housing, has shown significant increases, particularly in medical services, influenced by recent policy changes [4] - The rising costs in medical services are attributed to cuts in healthcare spending and potential tariffs on drug imports, leading to increased insurance premiums [4]

Investment Rating - The report upgrades the investment rating of the company to "Buy" with a target price of HKD 39.00, indicating a potential upside of 25.0% from the current price of HKD 31.20 [1][15]. Core Insights - The report highlights that the company's derivative business is accelerating, which is a key driver for the upgraded rating. The company maintains a leading position in high-quality IP reserves and is expected to benefit from the expansion of IP derivative products [1][5]. - The financial outlook for the company shows a mixed performance, with expected revenue growth stabilizing in the online business for 2025, despite a projected decline in copyright operations revenue [5][10]. Financial Overview - Revenue projections for the company are as follows: - 2023: RMB 7,012 million - 2024: RMB 8,121 million - 2025E: RMB 7,439 million - 2026E: RMB 8,067 million - 2027E: RMB 8,403 million - The year-on-year growth rates show a decline of 8.0% in 2023, followed by a recovery of 15.8% in 2024, and further fluctuations in subsequent years [2][10][16]. - Net profit estimates are: - 2023: RMB 1,130 million - 2024: RMB 1,142 million - 2025E: RMB 1,348 million - 2026E: RMB 1,486 million - 2027E: RMB 1,659 million - The net profit growth rate is expected to be 24.8% in 2025, following a slight increase in 2024 [2][10][16]. Business Segment Performance - The online business revenue showed a slight increase of 2% year-on-year, with a stable monthly active user (MAU) count of 10.3 million and a 5% increase in paying users to 9.2 million [5][9]. - The report notes a significant decline in revenue from copyright operations, down 46% year-on-year, primarily due to delays in new content releases [5][9]. Valuation and Market Position - The report maintains the non-IFRS net profit expectations for 2025/26 and adjusts the valuation to 2026, referencing an average price-to-earnings (P/E) ratio of 25 times for comparable companies [5][10]. - The company is positioned to leverage its IP reserves and the integration of AI-generated content (AIGC) to enhance efficiency and accelerate the adaptation of mid-tier IP into visual formats [5][10].

Group 1: Lexin Group (乐信集团) - The company is experiencing a continuous improvement in profitability, with a significant year-on-year net profit growth of 126% in Q2 2025, reaching 511 million yuan, and a quarter-on-quarter increase of 19% [1][2] - The improvement in profitability is primarily attributed to a decrease in provisioning expenses and an increase in revenue, with the net take rate reaching 1.92%, up 34 basis points quarter-on-quarter [2] - The company maintains a buy rating with a target price of $11.80, indicating a potential upside of 73.5% from the current price of $6.80 [1][2] Group 2: Legend Biotech (传奇生物) - The company reported adjusted earnings in Q2 2025, with Carvykti sales reaching $439 million, marking a 19% year-on-year and 136% quarter-on-quarter increase, setting a new record for CAR-T therapy sales in a single quarter [8][9] - Despite a net loss of $125 million, the company achieved adjusted net profit of $10 million after excluding non-operating items, indicating a turnaround from previous losses [8] - The target price has been raised to $74, reflecting a potential upside of 100% from the current price of $37 [8][9] Group 3: Rui Pu Lan Jun (瑞浦兰钧) - The company experienced a 25% revenue growth in the first half of 2025, with sales of lithium battery products doubling year-on-year to 32.4 GWh [10][11] - Gross margin improved significantly, rising by 5.9 percentage points to 8.5%, while net loss decreased by 85% to 65.32 million yuan [10] - The target price has been adjusted to 15.46 HKD, indicating a potential upside of 33.8% from the current price of 11.55 HKD [10][11] Group 4: Battery Industry - In July 2025, the growth rate of battery installations slowed, with a total of 55.9 GWh installed, reflecting a year-on-year increase of 34.3% but a month-on-month decrease of 4% [14][15] - Battery exports remained robust, with July exports reaching 23.2 GWh, a year-on-year increase of 35.4%, despite a month-on-month decline of 4.7% [15] - The supply-demand balance is expected to support lithium prices, especially with the suspension of operations at a key lithium mine [15]

Investment Rating - The report maintains a "Buy" rating for the company, Legend Biotech (LEGN US), with a target price raised to $74.00, indicating a potential upside of 100% from the current price of $37.00 [2][12]. Core Insights - The company achieved adjusted profitability in Q2 2025, driven by strong sales growth of Carvykti, with sales reaching $439 million, marking a year-over-year increase of 19% and a sequential increase of 136% [6]. - The report highlights optimistic sales expectations for Carvykti due to capacity expansion, improved production efficiency, and accelerated demand from the community healthcare market [2][6]. - The company is projected to reach operational breakeven by the end of 2025 and net profit breakeven in 2026 [6]. Financial Performance - Revenue forecasts for 2025, 2026, and 2027 have been adjusted upwards by 1-6%, reflecting a more optimistic outlook for Carvykti sales driven by new capacity and market penetration [6][7]. - The projected revenues for 2025, 2026, and 2027 are $1,016 million, $1,436 million, and $1,811 million respectively, with gross profit margins improving to 62.4%, 64.3%, and 66.8% [13][14]. - The company reported a net loss of $127.5 million in Q2 2025, but adjusted net profit was achieved after excluding non-operating items [6][13]. Market Position and Growth Potential - The report emphasizes that the current stock price is significantly undervalued, and the company is well-positioned for growth with a projected peak sales potential of $6.9 billion for Carvykti [6][7]. - The expansion of production capacity in the U.S. and Belgium is expected to enhance annual sales potential to over $4 billion [6]. - The report notes that the number of authorized treatment centers in the U.S. has increased to 123, improving community accessibility for Carvykti [6].

Investment Rating - The industry rating is "Leading," indicating that the covered industry is expected to perform better than the benchmark index over the next 12 months [3]. Core Insights - The MSCI Information Technology Index increased by 4.2% from July 12 to August 11, outperforming the MSCI Global Index, which rose by 1.7% [1]. - TSMC reported a revenue of NT$323.2 billion in July, a year-on-year increase of 26%, indicating strong demand for advanced processes [3]. - The semiconductor equipment import value in June grew by 19% year-on-year, reflecting sustained high levels of investment in domestic semiconductor manufacturing [3]. - The U.S. semiconductor tariff policy announced on August 6 is expected to have a smaller impact than previously anticipated, particularly for companies like TSMC that are investing heavily in U.S. manufacturing [3]. Summary by Sections Industry Performance - The MSCI Global Index and the CSI 300 Index have recorded three consecutive months of growth, although the rate of increase has slowed [1]. - The Hang Seng Technology Index rebounded with a 4.0% increase this month, outperforming the Hang Seng Index, which rose by 3.2% [1]. Company-Specific Insights - TSMC's revenue growth is attributed to strong demand for its 2nm technology, with expectations for continued growth in AI-related revenues [3]. - The average spot price for DDR5 (16GB) has stabilized since July, while contract prices for DDR4 (8GB) and NAND Flash (128GB) continue to rise [3]. Market Trends - The report anticipates that storage prices will remain strong in the second half of 2025, supported by ongoing demand [3]. - The report suggests that the tariff policy may accelerate domestic substitution and lead to some redundancy in the global semiconductor supply chain, benefiting upstream equipment suppliers [3].

交银国际研究 行业更新 电池行业月报 2025 年 8 月 12 日 7 月电池装车量增速放缓；关税维持暂缓，预计 8 月电池出口维持增势 估值概要 | 公司名称 | 股票代码 | 评级 | 目标价 | 收盘价 | | -----每股盈利----- | ----市盈率---- | | | ----市账率---- 股息率 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | | | | FY25E | | | FY26E FY25E FY26E FY25E FY26E | | | FY25E | | | | | | (当地货币) (当地货币) (报表货币) (报表货币) | | | (倍) | (倍) | (倍) | (倍) | (%) | | 宁德时代 | 300750 CH | 买入 | 314.11 | 263.66 | 14.358 | 15.517 | 18.4 | 17.0 | 3.92 | 3.32 | NA | | 亿纬锂能 | 300014 CH | 买入 | 56.51 | 46 ...

Investment Rating - The report maintains a "Buy" rating for the company, Lexin Group (LX US), with a target price of $11.80, indicating a potential upside of 84.1% from the current price of $6.41 [1][2][9]. Core Insights - The company's profitability is on a continuous improvement path, driven by a decrease in provisioning costs and an increase in technology-enabled revenue [5]. - The net profit for Q2 2025 reached 511 million RMB, showing a significant year-on-year increase of 126% and a quarter-on-quarter increase of 19% [5]. - The report highlights the company's strong performance in the e-commerce sector, with transaction amounts significantly increasing year-on-year and quarter-on-quarter [5]. - Shareholder returns are expected to improve, with a dividend payout ratio increasing from 25% in the first half of 2025 to 30% in the second half [5]. - The asset quality is showing a positive trend, with a decrease in the overdue rate [5]. Financial Overview - Revenue projections for Lexin Group are as follows: 13,057 million RMB in 2023, 14,204 million RMB in 2024, and an estimated 13,871 million RMB in 2025, reflecting a year-on-year growth of 32.3% in 2023 and a decline of 2.3% in 2025 [4][13]. - The net profit is projected to be 2,008 million RMB in 2025, representing a year-on-year increase of 82.4% [5][8]. - The company's price-to-earnings ratio is expected to be below 4 times in 2025, indicating an attractive valuation [5]. - The report anticipates a net take rate improvement, with projections of 1.88% for 2025 and 2.47% for 2026 [8]. Market Performance - The stock has shown a year-to-date change of 10.52% and has a market capitalization of approximately 849.90 million USD [4]. - The stock's 52-week high and low are 11.43 USD and 1.63 USD, respectively, indicating significant volatility and potential for growth [4]. Conclusion - The report concludes that Lexin Group's improving profitability, strong revenue growth in technology-enabled services, and attractive valuation make it a compelling investment opportunity [5][8].

Group 1: Company Insights - Semiconductor company, 中芯国际, reported a 2Q25 revenue decline of 1.7% with a gross margin of 20.4%, exceeding expectations due to growth in 8-inch products [1][2] - Management guidance for 3Q25 indicates a revenue recovery with a projected growth of 5%-7% and a gross margin forecast of 18%-20% [1][2] - The company is expected to add 1.1 million pieces of 12-inch monthly capacity in 3Q25, with an average selling price (ASP) anticipated to be higher than 2Q25 but slightly lower than 1Q25 [2] Group 2: Automotive Industry Insights - In July, the penetration rate of new energy vehicles reached 54%, marking a year-to-date high, with retail sales of new energy vehicles at 987,000 units, a year-on-year increase of 12% [3][4] - The overall retail sales of passenger cars in July were 1.826 million units, showing a year-on-year increase of 6.3% but a month-on-month decline of 12.4% [3] - The automotive market is expected to see gradual recovery in retail sales due to the upcoming launch of several new models, including 理想 i6 and 小鹏 P7 [7] Group 3: Real Estate Industry Insights - The real estate market experienced a seasonal decline in supply and demand, with total sales in July dropping 38.1% month-on-month to 229.4 billion yuan [9] - The average selling price and sales area decreased by 21.4% and 21.8% respectively in July, reflecting seasonal factors [9] - Future policies are expected to support the market, focusing on urban village renovations and financial support [9]

Investment Rating - The report assigns a "Buy" rating to multiple companies in the automotive sector, indicating a positive outlook for their future performance [2][12][13]. Core Insights - In July, the penetration rate of new energy vehicles (NEVs) reached 54%, marking a new high for the year, with expectations for stable growth in the automotive market in August [1][5]. - The retail sales of passenger vehicles in July were 1.826 million units, showing a year-on-year increase of 6.3% but a month-on-month decline of 12.4% [5]. - The cumulative retail sales for the first seven months of 2025 reached 12.728 million units, reflecting a year-on-year growth of 10.1% [5]. - Domestic brands outperformed the overall industry, with retail sales of 1.21 million units in July, a year-on-year increase of 14% [5]. - The report highlights that NEV retail sales in July were 987,000 units, with a year-on-year increase of 12% [5]. Summary by Sections Market Performance - The automotive market entered a sales lull in July, with a slight decline in month-on-month sales but maintained year-on-year growth due to trade-in programs [5]. - The market share of domestic brands increased to 65.9%, while mainstream joint venture brands saw a decline in retail sales [5]. New Energy Vehicles - The NEV penetration rate for the first seven months of 2025 was 50.7%, with July's rate at 54%, an increase of 2.7 percentage points year-on-year [5]. - The report notes that the export of NEVs maintained a strong growth trend, with July exports totaling 213,000 units, a year-on-year increase of 120.4% [5]. Investment Opportunities - The report suggests that the upcoming launch of several new models, including Li Auto's i6 and the new XPeng P7, will enhance market supply and drive retail sales recovery [5]. - Companies to watch include BYD, XPeng Motors, and Geely, all rated as "Buy" due to their potential for growth and market performance [5][12].

Group 1: 华虹半导体 - The company experienced a rebound in gross margin, with a notable demand for power management devices, leading to an upward revision in profit forecasts [1][2] - For Q2 2025, revenue reached $566 million, slightly exceeding guidance, with a gross margin of 10.8%, surpassing expectations [1] - The management indicated that price adjustments made in Q2 2025 will reflect more significantly in Q3 and Q4, with Q3 revenue guidance set between $620 million and $640 million [1][2] Group 2: 和黄医药 - The company faced short-term pressure in H1 2025, with total revenue declining by 9% year-on-year, significantly impacted by competition in mainland China [3][4] - The revenue from oncology and immunology businesses dropped by 15%, leading to a downward revision of the full-year revenue guidance from $350-450 million to $270-350 million [3] - Despite the challenges, the company is expected to achieve operational breakeven in H2 2025 [3][4] Group 3: 爱旭股份 - The company reported a profit of 63 million RMB in Q2 2025, marking a significant turnaround, with a gross margin of 7.4%, up 6.9 percentage points from the previous quarter [9] - The shipment volume of ABC components was 4.03 GW, although it saw an 11% quarter-on-quarter decline, with overseas sales exceeding 40% [9] - The rising prices of silicon wafers since July may compress the profit margins of ABC components, and there are uncertainties regarding the potential cancellation of a 9% export tax rebate on photovoltaic products [9]